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Regulation of Glucose Homeostasis in Experimental Diabetes by Insulin and Antidiabetic Compounds Trigonella Foenum Graecum and Vanadium
Najma Zaheer Baquer, Asia Taha , Pardeep Kumar, R.K.Kale and Deepak Sharma School of Life Sciences, Jawaharlal Nehru University, New Delhi.
In the last fifteen years my research group has been studying the effects of Trigonella foenum graecum and vanadium in reversing the changes in diabetic rat tissues. The changes studied include physiological, biochemical and molecular, in both insulin sensitive and those considered to be not sensitive to insulin action. As is very well known diabetes mellitus affects a large population of the world with increasing statistics to be classified as an epidemic. Nearly all tissue in the body are affected by this debilitating disease. We have followed the enzymatic changes in levels of important regulatory enzymes controlling glucose, fat and protein metabolism, including the oxidative mechanisms producing and removing free radicals, thereby controlling oxidative process. Tissues studied mainly included are liver, kidney, lens, brain and muscle. Since ion transport is also affected, enzyme controlling it, like Na + /K + ATPase has been monitored. A few glycolytic and gluconeogenic enzyme activities have been observed and changes and their reversal by Trigonella, vanadate and insulin administration has been carried out. Results of some of the findings will be presented and discussed with a brief description of the methodologies used. The results are very encouraging suggesting that Trigonella foenum graceum and vanadium, the latter given in low concentration, are as effective as insulin in reversing most of the diabetic changes/complications to normal levels and can be an effective substitute for insulin administration which is known to be a factor in insulin resistance with long term use.
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Risk Factors for Type 2 DDiabetes in Indian Diaspora
Prof. Praveen Sharma Department of Biochemistry, SMS Medical College, Jaipur-302004, India
Asian Indians are at increased risk of developing Type 2 diabetes and cardiovascular diseases (CVD) because of high prevalence of metabolic and life style risk factors. This study is a part of our ongoing project that examines prevailing risk factors in Indians which predispose them to diabetes and CVD. An assessment of conventional and novel risk factors, prothrombotic and proinflammatory markers for their role in development of Type 2 diabetes and CVD was made in Indians. Obesity, dysglycemia, dyslipidemia, hypertension, insulin resistance (IR), insulin secretory function, insulin sensitivity, FFA, C-reactive protein, fibrinogen and PAI-1 were analyzed and evaluated using standard methodology in normal healthy, IFG and diabetic population. Diabetes is a multifactorial disease caused by genetic as well as environmental factors. Lifestyle improvement and physical inactivity are particularly responsible for higher prevalence of metabolic syndrome (31%) and diabetes (13.7%) in Indian Population ranging in age from 25 to 70 years. Obesity, one of the important components of metabolic syndrome was found to be most prevalent risk factor as 39% subjects have waist circumference above 90 cm (men) and 80 cm (women). Asian Indians have been reported to have higher body fat, less lean body mass, high waist:hip ratio and enhanced visceral fat around abdominal region. Multiple Logistic Regression Analysis revealed Obesity, IR and FFA to be independent predictor for development of Type 2 diabetes in Indian subjects without genetic predisposition. Proinflammatory and prothombotic markers were found to be significantly raised in subjects with metabolic syndrome. Further these subjects have greater degree of IR as compared to those with genetic predisposition. Besides genetic predisposition, the life habit risk factors are equally important for diabetes epidemic in Indians. Early diagnosis and modification of life style can ward off final outcome of metabolic syndrome i.e. Diabetes and CAD. 
Insulin Receptor Gene Mutations in Type II Diabetes and in Associatd Syndromes
Diabetes Mellitus is prevalent throughout the world.It is predicted that the largest diabetics will be in India followed by China and United States. A dramatic increase in the incidence of diabetics to an epidemic proportion has caused major health concern globally. Type II DM is a multi factorial, polygenic and heterogeneous group of disorders, which occurs mainly due to inaction of Insulin. Insulin resistance contributes to the pathogenesis of Type II DM. Both genetic and environmental factors play an important role in pathogenesis of Type II DM. The molecular mechanisms involved in the development of diabetes are quite complex. During last decade polymorphisms of many genes and their association to diabetes and its complications have been studied by several experts. In genetically predisposed individuals, hyperglycemia is largely due to a combination of Insulin resistance and defect in Insulin secretion. The insulin unresponsiveness may occur due to1). Pre receptor or 2) receptor or 3) post insulin receptor defects. Diabetes mellitus (DM) is one of the most challenging health problem of the 21 st century. The most disturbing trend is shift in the age at diagnosis to a younger group.Difficulty of repeated administration of insulin and side effects of oral hypoglycemic drugs over long periods (sulphonylurea and biguanides) in patients with NIDDM (adult onset DM) has necessitated the search for oral herbal drug which should not only provides glycemic control but be able to correct diabetic dyslipidemia because major cause of mortality in diabetic population is cardiovascular disease. It is known that today world over there is renewed scientific interest in traditional medicine. WHO is currently promoting the inclusion of herbal drugs in National health care programme. There are many plants possessing antihyperglycemic activity which might prove useful source for the development of drugs e.g. Allium sativum, Azadirachta indica, Cassia auriculata, Eugenia jambolana,Ficus bengalensis, Gymnema Sylvestre, Momordica charantia, Pterocarpus marsupium and Trigonella foenum graecum which have been evaluated scientifically and in few active principles have been isolated. The aqueous extract of cassia auriculata leaves at the dose of 400mg /kg bw orally resulted in significant reduction in FBG at 24 hr in both mild(18%) and severe(21%) streptozotocin induced diabetic rats. The aqueous extract also exhibited significant hypolipidemic effect after 15days of treatment with 400mg/kg dose as evident from highly significant fall in triglycerides(17%mild :20%severe) and LDL-Cholesterol (18%mild:21%severe) and rise in HDL-Cholesterol (11%mild:16%severe). One of the significant finding is that effect of single dose persists till 48hrs. The antihyperglyemic compound(FIIc) isolated from fruit pulp of Eugenia jambolana at a dose of 10mg/kg bw showed 23.8% decrease in fasting blood glucose in mild and 29.5 fall in severe diabetic rats only after 90 min oral administration. GHb was also significantly decreased(55%) in severe diabetic rats after 15 days treatment .Both in vivo and in vitro studies showed release of insulin from beta-cells by FIIc.Histomorphological studies showed partial regeneration of beta-cells in diabetic rats. FIIc also showed extrapancreatic effect as there was increase in activites of key enzymes of gluconeogenesis. Total Cholesterol(19.6%), LDL-C(25%)and triglycerides(18%) were also decreased after 15days of treatment. Total lipids and HMG-CoA reductase activity in liver was significantly decreased . It also showed increased angiogenesis which is beneficial for tissue injury and cardiovascular diseases.Oral administration of FIIc (10mg/kgbw) efficiently attenuated the progression of early stages of diabetic nephropathy.
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